Publications by authors named "Ruohong Yan"

Claim this Profile
S
Simultaneous detection of dual biomarkers using hierarchical MoS nanostructuring and nano-signal amplification-based electrochemical aptasensor toward accurate diagnosis of prostate cancer.
Ruohong Yan, Na Lu, Suping Han, Zhanglu Lu, Yang Xiao

Biosens Bioelectron· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cytochrome P450 metabolic profiling of SMU-B in vitro, a novel small molecule tyrosine kinase inhibitor.
Ying Jiang, Zichao Yang, Lishun Zhang, Ruohong Yan, Siming Liu, Haikui Yang

J Pharm Biomed Anal· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasensitive aptamer-based protein assays based on one-dimensional core-shell nanozymes.
Rui Zhang, Na Lu, Jiaxing Zhang, Ruohong Yan, Jie Li

Biosens Bioelectron· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluation of 2-amino-4-(1,2,4-triazol)pyridine derivatives as potent EGFR inhibitors to overcome TKI-resistance.
Haikui Yang, Ruohong Yan, Ying Jiang, Zichao Yang, Xingmei Zhang

Eur J Med Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-triggered and enzyme-mimicking graphene oxide/polyvinyl alcohol/G-quartet supramolecular hydrogels.
Jiaxing Zhang, Na Lu, Hongzhen Peng, Jie Li, Ruohong Yan

Nanoscale· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy calculations.
Shanhe Wan, Ruohong Yan, Ying Jiang, Zhonghuang Li, Jiajie Zhang

J Biomol Struct Dyn· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors.
Siming Liu, Ying Jiang, Ruohong Yan, Zhonghuang Li, Shanhe Wan

Eur J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution strategy of ROS1 kinase inhibitors for use in cancer therapy.
Siming Liu, Haikui Yang, Ying Jiang, Tingting Zhang, Ruohong Yan

Future Med Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis